Fidelis Capital Partners LLC Buys New Position in Cardinal Health, Inc. (NYSE:CAH)

Fidelis Capital Partners LLC bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 1,934 shares of the company’s stock, valued at approximately $242,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. State Street Corp boosted its stake in Cardinal Health by 4.6% during the third quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after buying an additional 627,253 shares in the last quarter. Two Sigma Advisers LP lifted its holdings in Cardinal Health by 47.9% in the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock valued at $118,197,000 after acquiring an additional 346,362 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its position in shares of Cardinal Health by 230.0% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company’s stock valued at $52,819,000 after purchasing an additional 333,095 shares in the last quarter. Worldquant Millennium Advisors LLC grew its stake in shares of Cardinal Health by 77.3% in the 3rd quarter. Worldquant Millennium Advisors LLC now owns 593,007 shares of the company’s stock worth $65,539,000 after purchasing an additional 258,541 shares during the last quarter. Finally, Pacer Advisors Inc. raised its holdings in shares of Cardinal Health by 4.7% in the 3rd quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock worth $474,203,000 after purchasing an additional 191,568 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Price Performance

NYSE CAH opened at $126.38 on Wednesday. The firm has a market capitalization of $30.53 billion, a price-to-earnings ratio of 23.58, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63. The company has a 50 day simple moving average of $125.11 and a 200-day simple moving average of $118.51. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $132.84.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.60%. Cardinal Health’s payout ratio is 37.69%.

Analyst Ratings Changes

CAH has been the subject of a number of research reports. TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $132.00 to $145.00 in a research note on Monday, January 6th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a research report on Tuesday, January 7th. Argus set a $148.00 price target on Cardinal Health in a research report on Tuesday, February 4th. Finally, Morgan Stanley boosted their price objective on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a report on Friday, January 31st. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average target price of $139.36.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.